| Literature DB >> 36119818 |
Jinliang Ni1,2,3, Yidi Wang1,3, Haixian Zhang4,5, Keyi Wang1,3, Wei Song2,3, Ming Luo3, Jianping Che3, Jiang Geng3, Yunfei Xu3, Xudong Yao3, Junhua Zheng6, Ming Chen7, Bo Peng1,2,3, Weipu Mao1,7.
Abstract
This study was conducted to investigate the prognostic significance of a combination of fibrinogen and neutrophil-to-lymphocyte ratio (NLR) named the F-NLR score as a novel indicator and further create nomograms for predicting the prognosis of patients with renal cell carcinoma (RCC) treated with laparoscopic nephrectomy. A total of 425 patients with RCC who underwent laparoscopic nephrectomy were included in this study. Then, we divided the patients based on the cut-off values of their F-NLR score into three categories: F-NLR 2 (both high fibrinogen and NLR), F-NLR 0 (both low fibrinogen and NLR), and F-NLR 1 (remaining patients). Cox regression analysis was performed to investigate the predictive performance of the F-NLR score on overall survival (OS) and cancer-specific survival (CSS). Predictive nomograms of F-NLR were established and internally validated. Time-dependent receiver operating characteristic (ROC) curve analysis was performed to assess the predictive accuracy of the nomogram, NLR, and fibrinogen as prognostic markers. The F-NLR 0, 1, and 2 groups included 226 (53.2%), 147 (34.6%), and 52 (12.2%) patients, respectively. Cox regression analysis showed that a high F-NLR score was significantly associated with poor prognosis and acted as an independent prognostic factor for OS and CSS (all P < 0.05). Predictive nomograms with F-NLR for OS (C-index: 0.773) and CSS (C-index: 0.838) were well developed. Time-dependent ROC results showed that nomograms containing F-NLR had better predictive performance than NLR and fibrinogen. F-NLR score was a novel effective prognostic biomarker for patients with RCC undergoing laparoscopic nephrectomy. AJCREntities:
Keywords: F-NLR score; laparoscopic nephrectomy; prognostic biomarker; renal cell carcinoma
Year: 2022 PMID: 36119818 PMCID: PMC9442019
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 5.942